The Pharmaceutical Research and Manufacturers of America is taking a page from its pricing defense playbook for retail pharmacy drugs to highlight how hospitals and others in the supply chain contribute to high prices in the commercial insurance market for drugs administered by physicians and other providers.
For the past few years, PhRMA has worked to implicate pharmacy benefit manager and insurance plan rebating practices as the cause of high prices for drugs sold through retail pharmacy...